Preeclampsia
Reproductive·MeSH: Pre-Eclampsia
Prevalence
30.0 / 100K
2 drugs in development·2 companies·3 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| magnesium | EXELIXIS, INC. (EXEL) |
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| amag-423 | AMAG PHARMACEUTICALS, INC. (AMAG) |
Compare drugs
Frequently asked questions
How many drugs are in development for Preeclampsia?
BioSniper tracks 2 drugs in development for Preeclampsia across 2 companies.
How many clinical trials target Preeclampsia?
There are 3 clinical trials targeting Preeclampsia tracked by BioSniper.
What is the prevalence of Preeclampsia?
The estimated prevalence of Preeclampsia is approximately 30.0 per 100,000 population.
Deep-dive into Preeclampsia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis